Duration of Dual Antiplatelet Therapy After PCI
You should discontinue clopidogrel and continue apixaban alone if it has been >12 months since your PCI for stable coronary disease, or >12 months since PCI for acute coronary syndrome.
Determining Your Timeline and Next Steps
The critical decision point depends on two factors: (1) how many months have elapsed since your PCI, and (2) whether you had stable coronary disease or acute coronary syndrome (ACS) at the time of PCI.
If Your PCI Was for Stable Coronary Disease (No Recent Heart Attack)
The 2021 ACC Expert Consensus provides clear guidance for patients on anticoagulation who undergo PCI for stable ischemic heart disease 1:
- <6 months post-PCI: Stop aspirin, continue clopidogrel, and continue apixaban
- 6-12 months post-PCI: Continue clopidogrel with apixaban until you reach 12 months
- >12 months post-PCI: Stop clopidogrel and continue apixaban alone
If Your PCI Was for Acute Coronary Syndrome (Heart Attack or Unstable Angina)
For ACS patients, the timeline differs slightly 1:
- <12 months post-ACS: Stop aspirin, continue clopidogrel, and continue apixaban
- >12 months post-ACS: Stop clopidogrel and continue apixaban alone
The key distinction is that ACS patients should continue dual therapy (apixaban + clopidogrel) for the full 12 months, whereas stable disease patients may stop clopidogrel at 12 months regardless of when they stopped aspirin.
Why This Approach
The 2021 ACC guidelines prioritize clopidogrel over aspirin when combining antiplatelet therapy with oral anticoagulation because this combination reduces bleeding risk while maintaining protection against both stroke and coronary thrombosis 1. Aspirin should have been stopped early (ideally at hospital discharge or within the first few months), leaving you on the combination of apixaban plus clopidogrel.
High-Risk Exceptions
You may need to continue clopidogrel beyond 12 months if you have 1:
- Complex coronary anatomy (multiple stents, total stent length >60mm, bifurcation lesions)
- History of stent thrombosis
- Multiple vessels treated
- Chronic total occlusion intervention
- AND you have low bleeding risk
Conversely, if you have high bleeding risk and low ischemic risk, you could potentially stop clopidogrel earlier than 12 months, but this requires discussion with your cardiologist 1.
Critical Caveats
Do not stop clopidogrel abruptly without discussing with your cardiologist, especially if you fall into high-risk categories. The guidelines emphasize that premature discontinuation of antiplatelet therapy increases thrombotic risk 2.
The Canadian guidelines similarly support this approach, recommending dual therapy (oral anticoagulant + clopidogrel) for up to 12 months after PCI, followed by oral anticoagulant alone 3, 4. The 2018 North American consensus reinforces that most patients should discontinue antiplatelet therapy at 12 months and continue stroke-prevention doses of oral anticoagulant alone 5.
After stopping clopidogrel, ensure you continue apixaban at the full stroke-prevention dose (typically 5 mg twice daily, or 2.5 mg twice daily if you meet dose-reduction criteria) 6.